Literature DB >> 25408827

Inhibitors of Mutant IDH for the Treatment of Cancer.

Ahmed F Abdel-Magid1.   

Abstract

Entities:  

Year:  2014        PMID: 25408827      PMCID: PMC4233355          DOI: 10.1021/ml500400g

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  3 in total

1.  Differentiation therapy for IDH1/2 mutant malignancies.

Authors:  Francine E Garrett-Bakelman; Ari M Melnick
Journal:  Cell Res       Date:  2013-06-04       Impact factor: 25.617

2.  Targeting IDH: the next big thing in AML.

Authors:  Mark Levis
Journal:  Blood       Date:  2013-10-17       Impact factor: 22.113

3.  Releasing the block: setting differentiation free with mutant IDH inhibitors.

Authors:  Christopher J Pirozzi; Zachary J Reitman; Hai Yan
Journal:  Cancer Cell       Date:  2013-05-13       Impact factor: 31.743

  3 in total
  1 in total

Review 1.  Oxidative Phosphorylation: A Target for Novel Therapeutic Strategies Against Ovarian Cancer.

Authors:  Amruta P Nayak; Arvinder Kapur; Lisa Barroilhet; Manish S Patankar
Journal:  Cancers (Basel)       Date:  2018-09-18       Impact factor: 6.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.